CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
2021 · Cell Metabolism · 855 citations
https://doi.org/10.1016/j.cmet.2021.02.015
Q
Qing Yi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
311
Papers
13.8K
Citations
62
h-index
168
i10-index
Qing Yi is an academic researcher from Mianyang Normal University. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Immunotherapy and Immune Responses & T-cell and B-cell Immunology. The author has an h-index of 62, co-authored 265 publications.
ORCID: 0000-0003-1529-3398Papers by this author
worksA guideline on the molecular ecosystem regulating ferroptosis
2024 · Nature Cell Biology · 223 citations
https://doi.org/10.1038/s41556-024-01360-8
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
2018 · Cancer Cell · 158 citations
https://doi.org/10.1016/j.ccell.2018.05.004
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
2018 · Journal of Hematology & Oncology · 128 citations
https://doi.org/10.1186/s13045-018-0600-x
Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells
2005 · Experimental Hematology · 94 citations
https://doi.org/10.1016/j.exphem.2005.03.001
Nuclear Export of NF90 to Stabilize IL-2 mRNA Is Mediated by AKT-Dependent Phosphorylation at Ser647 in Response to CD28 Costimulation
2008 · The Journal of Immunology · 74 citations
https://doi.org/10.4049/jimmunol.180.1.222
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat